358 - Can you please advise what is required to substantiate a market share claim for a prescription product (i.e. will IMS data suffice)? How long must a market leadership position be maintained in order to make such a claim? How long is the claim valid?
-
Revised August 2019: Yes, IQVIA (formerly IMS Brogan) data can be considered for Rx product market share claims. Refer to this link for the requirements: http://www.paab.ca/resources/pdfs/supplementary-guideline.pdf
